![Nicholas Maragakis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicholas Maragakis
Corporate Officer/Principal en Q Therapeutics, Inc. .
Cargos activos de Nicholas Maragakis
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Q Therapeutics, Inc.
![]() Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Corporate Officer/Principal | - | - |
Historial de carrera de Nicholas Maragakis
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Q Therapeutics, Inc.
![]() Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
- Bolsa de valores
- Insiders
- Nicholas Maragakis
- Experiencia